Cox, Kristin E Turner, Michael A Lwin, Thinzar M Amirfakhri, Siamak Kelly, Kaitlyn J Hosseini, Mojgan Ghosh, Pradipta Obonyo, Marygorret Hoffman, Robert M Yazaki, Paul J
...
BackgroundGastric cancer poses a major diagnostic and therapeutic challenge as surgical resection provides the only opportunity for a cure. Specific labeling of gastric cancer could distinguish resectable and nonresectable disease and facilitate an R0 resection, which could improve survival.MethodsTwo patient-derived gastric cancer lines, KG8 and K...
Forsberg, Elise Resare, Alexander
This report presents a deep learning based approach for segmenting and characterizing tumor cell deaths using images provided by the Önfelt lab, which contain NK cells and HL60 leukemia cells. We explore the efficiency of convolutional neural networks (CNNs) in distinguishing between live and dead tumor cells, as well as different classes of cell d...
Kamalzade, Zahra Hoveizi, Elham Fereidoonnezhad, Masood
Published in
Molecular biology research communications
Toxicity and autophagy effects of a new complex of platinum II (CPC) were evaluated on HeLa cells cultured on a PCL/gelatin electrospinning scaffold. HeLa cells were treated with CPC on the first, third, and fifth days and the concentration of IC50 was determined. The autophagic and apoptotic effects of CPC were examined by MTT assay, Acridine Oran...
Elbadawi, Mostafa M Eldehna, Wagdy M El-Hafeez, Amer Ali Abd Somaa, Warda R Albohy, Amgad Al-Rashood, Sara T Agama, Keli K Elkaeed, Eslam B Ghosh, Pradipta Pommier, Yves
...
In this study, different assortments of 2-arylquinolines and 2,6-diarylquinolines have been developed. Recently, we have developed a new series of 6,7-dimethoxy-4-alkoxy-2-arylquinolines as Topoisomerase I (TOP1) inhibitors with potent anticancer activity. Utilising the SAR outputs from this study, we tried to enhance anticancer and TOP1 inhibitory...
Anurag, Meenakshi Lei, Jonathan Kim, Beom-Jun Singh, Purba Seker, Sinem Fandino, Diana Han, Airi Rehman, Saif Hu, Jianhong Korchina, Viktoriya
...
Genomic analysis has recently identified multiple ESR1 gene translocations in estrogen receptor alpha-positive (ERα+) metastatic breast cancer (MBC) that encode chimeric proteins whereby the ESR1 ligand binding domain (LBD) is replaced by C-terminal sequences from many different gene partners. Here we functionally screened 15 ESR1 fusions and ident...
Biran, Anat Yin, Shanye Kretzmer, Helene Ten Hacken, Elisa Parvin, Salma Lucas, Fabienne Uduman, Mohamed Gutierrez, Catherine Dangle, Nathan Billington, Leah
...
Chronic lymphocytic leukemia (CLL) is characterized by disordered DNA methylation, suggesting these epigenetic changes might play a critical role in disease onset and progression. The methyltransferase DNMT3A is a key regulator of DNA methylation. Although DNMT3A somatic mutations in CLL are rare, we found that low DNMT3A expression is associated w...
Yucer, Nur Ahdoot, Rodney Workman, Michael J Laperle, Alexander H Recouvreux, Maria S Kurowski, Kathleen Naboulsi, Diana J Liang, Victoria Qu, Ying Plummer, Jasmine T
...
Germline pathogenic mutations in BReast CAncer (BRCA1) genes are thought to drive normal fallopian tube epithelial (FTE) cell transformation to high-grade serous ovarian cancer. No human models capture the sequence of events for disease initiation and progression. Here, we generate induced pluripotent stem cells (iPSCs) from healthy individuals and...
Gill, Taylor Wang, Haichuan Bandaru, Raj Lawlor, Matthew Lu, Chenyue Nieman, Linda T Tao, Junyan Zhang, Yixian Anderson, Daniel G Ting, David T
...
MYC is a prolific proto-oncogene driving the malignant behaviors of numerous common cancers, yet potent and selective cell-permeable inhibitors of MYC remain elusive. In order to ultimately realize the goal of therapeutic MYC inhibition in cancer, we have initiated discovery chemistry efforts aimed at inhibiting MYC translation. Here we describe a ...
Bi, Junfeng Khan, Atif Tang, Jun Armando, Aaron M Wu, Sihan Zhang, Wei Gimple, Ryan C Reed, Alex Jing, Hui Koga, Tomoyuki
...
The highly lethal brain cancer glioblastoma (GBM) poses a daunting challenge because the blood-brain barrier renders potentially druggable amplified or mutated oncoproteins relatively inaccessible. Here, we identify sphingomyelin phosphodiesterase 1 (SMPD1), an enzyme that regulates the conversion of sphingomyelin to ceramide, as an actionable drug...
Chuang, Tsai-Der Quintanilla, Derek Boos, Drake Khorram, Omid
ObjectiveTo determine the expression and functional roles of indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO2) in leiomyoma.DesignExperimental study.SettingAcademic research laboratory.Patient(s)Women undergoing hysterectomy for leiomyoma.Intervention(s)Blockade of IDO1 and TDO2.Main outcome measure(s)Expression of IDO1 and...